MORANDI, Anita
 Distribuzione geografica
Continente #
NA - Nord America 6.468
EU - Europa 4.552
AS - Asia 3.425
SA - Sud America 528
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 150
OC - Oceania 12
Totale 15.336
Nazione #
US - Stati Uniti d'America 6.236
RU - Federazione Russa 1.936
SG - Singapore 1.418
GB - Regno Unito 839
CN - Cina 828
IT - Italia 563
BR - Brasile 406
HK - Hong Kong 358
VN - Vietnam 329
SE - Svezia 236
DE - Germania 212
IE - Irlanda 190
FR - Francia 175
FI - Finlandia 136
KR - Corea 119
CA - Canada 115
BD - Bangladesh 77
IN - India 51
UA - Ucraina 48
AR - Argentina 45
JP - Giappone 43
NG - Nigeria 36
NL - Olanda 36
TR - Turchia 34
ES - Italia 33
MX - Messico 32
ID - Indonesia 27
ZA - Sudafrica 27
IQ - Iraq 26
PL - Polonia 25
AT - Austria 23
TG - Togo 22
BJ - Benin 21
BE - Belgio 20
LT - Lituania 20
CR - Costa Rica 18
EC - Ecuador 17
UZ - Uzbekistan 15
PH - Filippine 14
CO - Colombia 13
GT - Guatemala 12
AU - Australia 11
JO - Giordania 11
SA - Arabia Saudita 10
VE - Venezuela 10
CL - Cile 9
CZ - Repubblica Ceca 9
GR - Grecia 9
HN - Honduras 9
PK - Pakistan 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
CW - ???statistics.table.value.countryCode.CW??? 8
KZ - Kazakistan 8
MA - Marocco 8
PE - Perù 8
TH - Thailandia 8
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 7
PR - Porto Rico 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
NI - Nicaragua 6
PT - Portogallo 6
SV - El Salvador 6
TN - Tunisia 6
NP - Nepal 5
BG - Bulgaria 4
BO - Bolivia 4
IL - Israele 4
RS - Serbia 4
AZ - Azerbaigian 3
BB - Barbados 3
EE - Estonia 3
GA - Gabon 3
MT - Malta 3
OM - Oman 3
SC - Seychelles 3
SI - Slovenia 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
DM - Dominica 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
IR - Iran 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
AW - Aruba 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 15.126
Città #
Dallas 973
Ashburn 817
Singapore 817
Moscow 669
San Jose 663
Southend 656
Chandler 397
Hong Kong 345
Jacksonville 281
Council Bluffs 210
Verona 201
Ann Arbor 197
Woodbridge 194
Dublin 186
Beijing 172
The Dalles 169
New York 165
Los Angeles 117
Ho Chi Minh City 99
Houston 91
Santa Clara 79
Hanoi 75
Wilmington 72
Princeton 63
Lawrence 61
Buffalo 60
Boardman 58
Bologna 53
Munich 51
São Paulo 49
Helsinki 47
London 45
Columbus 41
Tokyo 40
Jinan 39
Nanjing 35
Montreal 34
Dearborn 33
Orem 33
Chicago 31
Redondo Beach 31
Abuja 29
Amsterdam 28
Frankfurt am Main 28
Changsha 27
Redmond 26
Shenyang 26
Milan 25
Tianjin 25
Denver 24
Dong Ket 24
Hebei 24
Falls Church 22
Lomé 22
Turku 22
Atlanta 21
Cotonou 21
Seattle 21
Warsaw 21
Brussels 20
Johannesburg 20
Sindelfingen 20
Brooklyn 19
Seoul 19
Stockholm 19
Zhengzhou 19
Rome 18
North Bergen 17
Nuremberg 17
Phoenix 17
Toronto 17
Redwood City 16
Washington 16
Chennai 15
Da Nang 15
Baghdad 14
Manchester 14
Norwalk 14
San José 14
Hangzhou 13
San Francisco 13
Vilnius 13
Guatemala City 12
Jakarta 12
Nanchang 12
Ningbo 12
Tashkent 12
Charlotte 11
Haikou 11
Haiphong 11
McKinney 11
North Hollywood 11
Taiyuan 11
Vienna 11
Amman 10
Bari 10
Belo Horizonte 10
Cleveland 10
Lappeenranta 10
Mexico City 10
Totale 9.461
Nome #
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. 261
A Rare Case of Granuloma Annulare in a 5-Year-Old Child With Type 1 Diabetes and Autoimmune Thyroiditis 256
Anthropometric indices are not satisfactory predictors of metabolic comorbidities in obese children and adolescents. 254
13C/12C breath test ratio after the ingestion of a meal naturally enriched with (13C)carbohydrates is a surrogate marker of insulin resistance and insulin sensitivity in children and adolescents with Type 1 Diabetes 249
Feasibility and effectiveness of a distance-adapted physical activity intervention in adolescents with obesity during the COVID-19 pandemic 245
Glucose-independent association of adiposity and diet composition with cardiovascular risk in children and adolescents with type 1 diabetes 243
Diabetic ketoacidosis at diagnosis: role of family history and class II HLA genotypes 229
Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. 228
A girl with incomplete Prader-Willi syndrome and negative MS-PCR, found to have mosaic maternal UPD-15 at SNP array 217
A new index to simplify the screening of hypertension in overweight or obese youth 211
Estimation of newborn risk for child oradolescent obesity: lessons fromlongitudinal birth cohorts 207
Epidemiology of type 1 diabetes mellitus in the pediatric population in Veneto Region, Italy 206
Predictors of metabolic risk in childhood obesity 205
High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents 204
Prevalenza di obesità, sovrappeso e ipertensione in un campione di bambini del Comune di Verona 199
Bias in food intake reporting in children and adolescents with type 1 diabetes: the role of body size, age and gender 199
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents 197
Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity 189
Difficult Management of Glucose Homeostasis in a 21-Month-Old Child With Type 1 Diabetes and Unknown Glutaric Aciduria Type I: A Case Report 188
Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. 187
Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis 183
Metabolic and hormonal consequences of two different meals after a moderate intensity exercise bout in obese prepubertal children 182
Circulating mitochondrial DNA is decreased in children and adolescents with obesity and/or insulin resistance 181
Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children 181
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. 178
Biochemical parameters and anthropometry predict NAFLD in obese children 177
Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes 176
Minor diplotypes of FMO3 might protect children and adolescents from obesity and insulin resistance 175
Policaptil Gel Retard Intake Reduces Postprandial Triglycerides, Ghrelin and Appetite in Obese Children: A Clinical Trial 174
Prevention of obesity in toddlers (PROBIT): a randomised clinical trial of responsive feeding promotion from birth to 24 months 173
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 173
Cardiometabolic risk in children and adolescents with obesity: a position paper of the Italian Society for Pediatric Endocrinology and Diabetology 172
Nutrition habits of children and adolescents with type 1 diabetes changed in a 10 years span 171
Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics 170
Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. 169
Health consequences of obesity in children and adolescents 169
A new formula to improve the screening of impaired glucose tolerance in youths with overweight or obesity 168
A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. 166
Long chain fatty acids metabolism and cardiovascular risk factors in youth with type 1 diabetes 166
Central Systolic Blood Pressure Is Associated With Early Vascular Damage in Children and Adolescents With Type 1 Diabetes 166
FADS cluster variants are associated with insulin sensitivity in children and adolescents with overweight and obesity 163
Il trattamento con bifosfonati in età evolutiva. Aspetti generali e indicazioni nelle patologie secondarie dello scheletro- parte seconda 162
Epicardial fat, abdominal adiposity and insulin resistance in obese pre-pubertal and early pubertal children. 162
Childhood obesity classification systems and cardiometabolic risk factors: a comparison of the Italian, World Health Organization and International Obesity Task Force references 161
Protein Intake as a Risk Factor of Overweight/Obesity in 8- to 12-Year-Old Children 161
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 159
Estimation of Newborn Risk for Child or Adolescent Obesity: Lessons from Longitudinal Birth Cohorts 158
Safety and effectiveness of evinacumab in an infant with homozygous familial hypercholesterolemia: A new renaissance for the very young? 157
A new simple formula built on the American Academy of Pediatrics criteria for the screening of hypertension in overweight/obese children 157
Ability of triglyceride-glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity 156
Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a new CGM Metric in Children and Adolescents with Type 1 Diabetes using Different Treatment Modalities 156
Genetic Variation in Antioxidant Response Modulates the Level of Oxidative Stress in Youth with Type 1 Diabetes and Poor Glycemic Control 154
The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery 151
Effect of Maternal Obesity on Foetal Growth and Metabolic Health of the Offspring 150
Associations Between Type 2 Diabetes-Related Genetic Scores and Metabolic Traits, in Obese and Normal-Weight Youths 150
Cardiovascular risk factors in children and adolescents with type 1 diabetes mellitus: the role of insulin resistance and associated genetic variants 150
A new proposal for a second insulin bolus to optimize postprandial glucose profile in adolescents with type 1 diabetes 146
Glycaemic control metrics and metabolic dysfunction-associated steatotic liver disease in children and adolescents with type 1 diabetes 145
Primary congenital hypothyroidism: a clinical review 143
Nutritional education and carbohydrate counting in children with type 1 diabetes treated with continuous subcutaneous insulin infusion: the effects on dietary habits, body composition and glycometabolic control. 142
Il trattamento con bifosfonati in età evolutiva. Aspetti e indicazioni nelle patologie secondarie dello scheletro-parte prima. 137
Diet, physical, and biochemical characteristics of children and adolescents with type 1 diabetes: relationship between dietary fat and glucose control. 137
Body composition and insulin resistance in children 137
Correction to: A new proposal for a second insulin bolus to optimize postprandial glucose profile in adolescents with type 1 diabetes 136
Oxidative stress in youth with type 1 diabetes: Not only a matter of gender, age, and glycemic control 133
Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity 132
Serum zonulin as an index of glucose dysregulation in children and adolescents with overweight and obesity 131
Urogenital complications of obesity 130
Hepatic lipogenesis marked by GCKR-modulated triglycerides increases serum FGF21 in children/teens with obesity 129
Variant reclassification over time decreases the level of diagnostic uncertainty in monogenic obesity: Experience from two centres 128
Diet macronutrient composition reported before treatment predicts BMI change in obese children: the role of lipids. 128
Fluid intake and hydration status in obese vs normal weight children 128
Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes 126
Sex differences in cardiovascular risk factors of children and adolescents with type 1 diabetes mellitus: A role for diet? 125
Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. 125
The Q121 Variant of ENPP1 May Protect From Childhood Overweight/obesity in the Italian Population. 123
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 123
Interaction between Streptococcus pneumoniae and Staphylococcus aureus in paediatric patients suffering from an underlying chronic disease. 115
IGF1 and PPARG polymorphisms are associated with reduced estimated glomerular filtration rate in a cohort of children and adolescents with type 1 diabetes 112
Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes 103
Association of HDL-Cholesterol, hypertension and left ventricular hypertrophy in youths with overweight or obesity 98
The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document 98
Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype 94
The American Academy of Pediatrics hypertension guidelines identify obese youth at high cardiovascular risk among individuals non-hypertensive by the European Society of Hypertension guidelines 93
Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity 89
Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth 88
Screening for hypertension in young people with obesity: Feasibility in the real life 87
The risk of metabolic derangements is higher in children and adolescents with overweight or obesity born small for gestational age 85
Optimising healthcare transition of adolescents and young adults to adult care: a perspective statement of the Italian Society of Obesity 84
Lipid and saturated fatty acids intake and cardiovascular risk factors of obese children and adolescents 82
Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes 80
Phenotypes of prediabetes and metabolic risk in Caucasian youths with overweight or obesity 76
One-Hour Post-Load Plasma Glucose and Altered Glucometabolic Profile in Youths with Overweight or Obesity 76
Which Is the Most Appropriate Cut-Off of HbA1c for Prediabetes Screening in Caucasian Youths with Overweight or Obesity? 73
Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity 73
Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD? 72
Correction: Prevention of obesity in toddlers (PROBIT): a randomised clinical trial of responsive feeding promotion from birth to 24 months 69
Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity 68
High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity 64
Urogenital Complications: Renal Disease, Urolithiasis and Lower Urinary Tract Symptoms 62
Totale 15.076
Categoria #
all - tutte 51.736
article - articoli 50.225
book - libri 0
conference - conferenze 686
curatela - curatele 0
other - altro 518
patent - brevetti 0
selected - selezionate 0
volume - volumi 307
Totale 103.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022255 0 0 0 0 30 23 9 32 20 7 32 102
2022/20231.161 69 128 95 189 94 279 19 102 116 13 39 18
2023/2024839 25 61 72 87 89 152 42 45 10 47 116 93
2024/20252.191 114 107 117 416 88 73 110 138 285 177 190 376
2025/20267.234 420 356 975 1.116 1.706 432 636 340 493 371 192 197
2026/20271.150 97 190 186 663 14 0 0 0 0 0 0 0
Totale 15.336